Long-term Quality of Life and Prognostic Factors in Severe COVID-19 Patients and Their Relatives
Key facts
- Who runs it
- Centre Hospitalier Régional Metz-Thionville
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 800 people enrolled
- Started
- 10 Oct 2022
- Ended
- 29 Aug 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- COVID19-severe Patient
- family of COVID19-severe Patient
- Record updated
- 27 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- Adult patient
- Having stayed in a critical care unit (resuscitation, continuous monitoring, intensive care) at the Regional Hosiptal Center (CHR) Metz-Thionville for COVID-19 between March 2020 and March 2022
- Having given their oral consent to participate (telephone contact), or not having objected during their lifetime to the use of their hospital data for epidemiological research (deceased patients)
- The trusted person or closest family member will also be invited to participate
- The patients included will be those who were hospitalized in conventional critical care services, but also in functional units of so-called "ephemeral" critical care, armed in emergency in the context of a massive influx of victims (Cardiological Intensive Care, Post-Interventional Monitoring Room in the operating room, Dialysis Center)
Who cannot take part
- Cognitive disorders or lack of French language skills preventing response to evaluation questionnaires
- Patient under guardianship or deprivation of liberty
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective cohort study with multicenter retrospective data collection (CHR Metz-Thionville, Hôpital Mercy and Hôpital Bel Air).
Read full original descriptionShow less
Patients hospitalized for COVID-19 in a critical care unit between March 2020 and March 2022 will be contacted by telephone 24 months after their hospitalization by a doctor or intern from the intensive care unit. If the patient agrees to participate, he or she will then complete the study questionnaire items. Data concerning their hospital management between their hospitalization for COVID-19 and the 24-month call will then be extracted from their medical records.
The 2 groups in the trial
- COVID19-severe Patient
modified Medical Research Council dyspnea scale (mMRC), European Quality of Life 5 Dimensions and 5 Lines (EQ-5D-5L), the impact of event scale-revised (IES-R), The Hospital Anxiety and Depression Scale (HADS), the Montreal Cognitive Assessment (MoCA)- BLIND, Lawton instrumental activities of daily living (IADL) and Return to work scales
- family of COVID19-severe Patient
impact of event scale-revised (IES-R), The Hospital Anxiety and Depression Scale (HADS) scales
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment and Prognostic Factors of Long-term Quality of Life of Patients Hospitalized With Severe COVID-19 and Their Relatives
- Record updated
- 27 December 2024